The intravenous immunoglobulin market was valued at USD 18.48 Billion in 2025 and is expected to grow at a CAGR of 8.70%, reaching USD 42.56 Billion by 2035. The market growth is driven by increasing autoimmune and immunodeficiency disorders, rising availability of plasma-derived products, and improved regulatory approvals.
Base Year
Historical Period
Forecast Period
Compound Annual Growth Rate
8.7%
Value in USD Billion
2026-2035
*this image is indicative*
Intravenous immunoglobulin or IVIG is a therapy treatment targeted towards patients deficient of antibodies that would otherwise fight infections or are suffering from autoimmune diseases. Immunoglobulins are prepared by the immune system of people who are healthy and have sufficient antibodies. IVIG treatment response varies from person to person, and there is a likelihood that some patients may not respond to the treatment.
The EMR’s report titled “Intravenous Immunoglobulin Market Report and Forecast 2026-2035" offers a detailed analysis of the market based on the following segments:
Market Breakup by Type
Market Breakup by Applications
Market Breakup by Route of Administration
Market Breakup by End User
Market Breakup by Distribution Channel
Market Breakup by Region
The liquid form segment of the intravenous immunoglobulin market accounts for a substantial share, due to the ease of administering liquids intravenously, without concerns of mixing powders in required concentrations. Liquid immunoglobulin is collected from the blood plasma of the individuals only after screening them and making sure that they are healthy. The blood plasma collected is purified and is tested for serious infections such as AIDS and hepatitis.
Lyophilised or powder form of intravenous immunoglobulin is administered within 2-3 hours of its dissolution. It offers greater flexibility in changing dosages for patients new to the treatment and trying out various concentrations to find an ideal match.
Intravenous immunoglobulin is typically given to patients in hospitals or clinics but in some cases it can be administrated through home care, under careful supervision of a professional nurse. As IVIG treatment tends to be long-term, many patients start out with treatments in hospitals or clinics, and later moving on to home care.
Administration of intravenous immunoglobin through home care is preferable for long-term treatment as it is more comfortable for patients to receive treatment in the comfort of their own home, due to which growth of the home care segment in the intravenous immunoglobulin market is expected. Depending upon the region and insurance coverage, home care may or may not be more expensive than receiving intravenous immunoglobin in hospitals or clinics.
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis. The report gives a detailed analysis of the following key players in the global intravenous immunoglobulin market, covering their competitive landscape and latest developments like mergers, acquisitions, investments, and expansion plans.
CSL Limited founded in 1916 has its headquarter in Melbourne, Australia. This biotechnology company mainly focusses on innovating medical solutions to treat bleeding disorders, neurological disorders, and other disorders or medical problems.
Grifols, S.A. was established in 1940 and has its headquarter in Barcelona, Spain. It is a pharmaceutical and chemical manufacturer known for the development of blood-plasma based products. It also supplies reagents, devices, and instruments for laboratories involved in clinical testing.
Octapharma AG was incorporated in 1983 and has its headquarter in Lachen, Switzerland. It is a family owned company and develops human proteins from human cell lines and plasma. They typically manufacture products that treat bleeding disorders and other rare diseases.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other market players include Shanghai RAAS Blood Products Co., Ltd., Biotest AG, and LFB S.A, among others.
Upto 15% Off
USD
$3299 $2969
$5499 $4949
$6999 $5949
$8199 $6969
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
The market is expected to grow at a CAGR of 8.70% between 2026 and 2035.
The major market drivers are increasing prevalence of auto immune diseases, growing geriatric population, and technological advancements in intravenous immunoglobulin therapies.
The market is segmented based on form, product, indication, distribution channels, end use, and region.
Key trends of the market are increasing use of intravenous immunoglobulin therapies for multiple conditions, home care options for long-term and mor comfortable care, and research into methods of lowering costs of the therapy.
The regional markets can be divided into North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa.
Key distribution channels of the market are hospital pharmacies, retail pharmacies, and others.
Key players in the global intravenous immunoglobulin market are CSL Limited, Grifols, S.A., Octapharma AG, Shanghai RAAS Blood Products Co., Ltd., Biotest AG, and LFB S.A, among others.
Intravenous immunoglobulin, also abbreviated as IVIG, is a therapy treatment for people who are deficient of antibodies and have weak immune systems.
Immunoglobulins are prepared from samples donated by people who have immune systems that are healthy with sufficient antibodies.
IVIG response varies from person to person, and some may not even respond to the treatment. Typically, the treatment is long-term.
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Type |
|
| Breakup by Applications |
|
| Breakup by Route of Administration |
|
| Breakup by End User |
|
| Breakup by Distribution Channel |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
Single User License
One User
USD 5,499
USD 4,949
tax inclusive*
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Share